SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Cannabigerolic acid (CBGA), a precursor cannabinoid in Cannabis sativa, has recently been found to have anticonvulsant properties in the Scn1a+/- mouse model of Dravet syndrome.